Aveanna Healthcare (NASDAQ:AVAH) Upgraded to "Neutral" at UBS Group

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Aveanna Healthcare (NASDAQ:AVAH - Get Free Report) was upgraded by equities researchers at UBS Group from a "sell" rating to a "neutral" rating in a research report issued on Tuesday, Marketbeat.com reports. The brokerage presently has a $8.00 price target on the stock, up from their prior price target of $6.75. UBS Group's price objective would suggest a potential upside of 7.10% from the stock's current price.

Several other brokerages also recently issued reports on AVAH. Barclays initiated coverage on shares of Aveanna Healthcare in a report on Wednesday, July 2nd. They set an "equal weight" rating and a $5.50 price target for the company. Truist Financial dropped their target price on shares of Aveanna Healthcare from $6.00 to $5.00 and set a "hold" rating for the company in a research note on Wednesday, July 16th. Raymond James Financial raised shares of Aveanna Healthcare from a "market perform" rating to an "outperform" rating and set a $9.00 target price for the company in a research note on Monday, August 11th. Wall Street Zen raised shares of Aveanna Healthcare from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 9th. Finally, Jefferies Financial Group raised shares of Aveanna Healthcare from a "hold" rating to a "buy" rating and dropped their target price for the stock from $6.25 to $6.00 in a research note on Monday, July 21st. Three research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $7.50.

Aveanna Healthcare Trading Up 6.1%

AVAH stock traded up $0.43 during trading on Tuesday, hitting $7.47. 1,547,703 shares of the stock traded hands, compared to its average volume of 1,739,328. Aveanna Healthcare has a one year low of $3.67 and a one year high of $7.69. The stock has a market cap of $1.56 billion, a price-to-earnings ratio of 93.38 and a beta of 1.95. The company has a 50 day simple moving average of $4.97 and a 200 day simple moving average of $4.96.

Insider Buying and Selling at Aveanna Healthcare

In other news, major shareholder J.H. Whitney Equity Partners V sold 750,000 shares of the company's stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $5.20, for a total value of $3,900,000.00. Following the completion of the transaction, the insider owned 28,890,756 shares in the company, valued at $150,231,931.20. This represents a 2.53% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, major shareholder Robert M. Williams, Jr. sold 750,000 shares of the business's stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $5.20, for a total transaction of $3,900,000.00. Following the completion of the sale, the insider directly owned 28,890,756 shares in the company, valued at approximately $150,231,931.20. This represents a 2.53% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 2,295,145 shares of company stock valued at $11,941,141 over the last 90 days. Company insiders own 7.80% of the company's stock.

Institutional Trading of Aveanna Healthcare

Institutional investors have recently made changes to their positions in the business. Millennium Management LLC lifted its position in shares of Aveanna Healthcare by 105.0% in the fourth quarter. Millennium Management LLC now owns 400,374 shares of the company's stock worth $1,830,000 after purchasing an additional 205,023 shares in the last quarter. Legal & General Group Plc lifted its position in shares of Aveanna Healthcare by 577.0% in the fourth quarter. Legal & General Group Plc now owns 36,409 shares of the company's stock worth $166,000 after purchasing an additional 31,031 shares in the last quarter. Deutsche Bank AG lifted its position in shares of Aveanna Healthcare by 32.1% in the fourth quarter. Deutsche Bank AG now owns 34,564 shares of the company's stock worth $158,000 after purchasing an additional 8,396 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new stake in shares of Aveanna Healthcare in the fourth quarter worth $223,000. Finally, Teacher Retirement System of Texas lifted its position in shares of Aveanna Healthcare by 50.9% in the first quarter. Teacher Retirement System of Texas now owns 49,881 shares of the company's stock worth $270,000 after purchasing an additional 16,835 shares in the last quarter. Institutional investors own 87.96% of the company's stock.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.